Antiretroviral chemotherapy.
Saag
M S
MS
Division of Infectious Diseases, University of Alabama at Birmingham, USA.
Schooley
R T
RT
D000480:Alkynes; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D048588:Benzoxazines; D003521:Cyclopropanes; D020008:Delavirdine / Q000627:therapeutic use; D016049:Didanosine / Q000627:therapeutic use; D015224:Dideoxynucleosides / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D019888:Nelfinavir / Q000627:therapeutic use; D019829:Nevirapine / Q000627:therapeutic use; D010078:Oxazines / Q000627:therapeutic use; D019438:Ritonavir / Q000627:therapeutic use; D019258:Saquinavir / Q000627:therapeutic use; D018119:Stavudine / Q000627:therapeutic use; D016047:Zalcitabine / Q000627:therapeutic use; D015215:Zidovudine / Q000627:therapeutic use; D000099227:Abacavir
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D020008:Delavirdine; D016049:Didanosine; D015224:Dideoxynucleosides; D019469:Indinavir; D019259:Lamivudine; D019888:Nelfinavir; D019829:Nevirapine; D010078:Oxazines; D019438:Ritonavir; D019258:Saquinavir; D018119:Stavudine; D016047:Zalcitabine; D015215:Zidovudine; D000099227:Abacavir; C098320:efavirenz